Yonsei Med J.  2007 Dec;48(6):949-954. 10.3349/ymj.2007.48.6.949.

IGF-1 Counteracts TGF-beta-Mediated Enhancement of Fibronectin for in Vitro Human Lens Epithelial Cells

Affiliations
  • 1Department of Ophthalmology, Inje University College of Medicine, Seoul Paik Hospital, Seoul, Korea.
  • 2Myunggok Eye Research Institute at Kim's Eye Hospital, Konyang University College of Medicine, Nonsan, Korea. joonhlee@konyang.ac.kr
  • 3Department of Ophthalmology, Institute of Vision Research, Cornea Dystrophy Research Institute, Yonsei University College of Medicine, Seoul, Korea. eungkkim@yuhs.ac
  • 4BK21 Project Team of Nanobiomaterials for Cell-based Implants, Yonsei University, Seoul, Korea.

Abstract

PURPOSE: To determine whether insulin-like growth factor (IGF-1) affects transforming growth factor (TGF-beta)- mediated fibronectin accumulation in human lens epithelial cell line (HLE B-3) cells. MATERIALS AND METHODS: HLE B-3 cells were incubated for 24 hours with TGF-beta (10ng/ mL), IGF-1 (10ng/mL), or both. Expression of the fibronectin gene was determined using a real-time reverse transcriptase-polymerase chain reaction (RT-PCR). Fibronectin levels were examined using western blot analysis and immunofluorescence staining. RESULTS: Expression of the fibronectin gene was not different between the TGF-beta/IGF-1 treated group and the TGF-beta treated group (p= 0.116). However, western blot analysis demonstrated decreased fibronectin levels in human lens epithelial cells treated with TGF-beta and IGF-1 compared to those treated with TGF-beta only (p < 0.01). Immunofluorescence staining disclosed inhibition of TGF-beta-induced fibronectin in the presence of IGF-1. CONCLUSION: This study suggests that IGF-1 counteracts TGF-beta-mediated fibronectin accumulation in human lens epithelial cells.

Keyword

Fibronectin; IGF-1; lens epithelial cells; TGF-beta

MeSH Terms

Cell Line
Epithelial Cells/cytology/*drug effects/metabolism
Fibronectins/*genetics/metabolism
Fluorescent Antibody Technique
Gene Expression Regulation/drug effects
Humans
Insulin-Like Growth Factor I/*pharmacology
Lens, Crystalline/cytology
Reverse Transcriptase Polymerase Chain Reaction
Transforming Growth Factor beta/*pharmacology

Figure

  • Fig. 1 The real-time polymerase chain reaction (PCR) demonstrated that no change was detected in the expression of the fibronectin gene following 24 hour treatment with insulin-like growth factor (IGF)-1 in human lens epithelial cells (HLE B-3). The amount of fibronectin transcripts significantly increased following treatment with TGF-β1. There was no significant difference in the amount of fibronectin (FN) gene transcripts between control and IGF-1 treatment groups, and between TGF-β1 only and TGF-β1 and IGF-1 treatment groups. The graphs show the mean values of the three independent experiments with the error bars representing the standard deviation.

  • Fig. 2 IGF-1 counteracts TGF-β-mediated fibronectin accumulation in the human lens epithelial cell line (HLE B-3 cells). HLEB-3 cells in serum-free media were incubated for 24 hours with TGF-β1 (10 ng/mL), IGF-1 (10 ng/mL), or both. Fibronectin levels increased following treatment with TGF-β1 (10 ng/mL) in the western blot analysis. However, fibronectin (FN) levels decreased after treatment with TGF-β1 (10 ng/mL) and IGF-1 (10 ng/mL) when compared to treatment with TGF-β1 (10 ng/mL) only. Values in these graphs represent the mean of the three experiments and error bars represent the standard deviation. Values were normalized to the density of the respective β-actin band.

  • Fig. 3 Comparative fluorescent micrographs showing IGF-1 inhibition of TGF-β-mediated fibronectin accumulation in HLE B-3 cells. Cells were maintained (A) in serum free media alone; (B) treated with 10 ng/mL TGF-β1 for 24 hr; (C) treated with 10 ng/mL IGF-1 for 24 hr; (D) treated with 10 ng/mL IGF-1 in the presence of 10 ng/mL TGF-β1 for 24 hr. The bar represents 50 µm in A-D.


Reference

1. Hales AM, Schulz MW, Chamberlain CG, McAvoy JW. TGF-beta1 induces lens cells to accumulate alpha-smooth muscle actin, a marker for subcapsular cataracts. Curr Eye Res. 1994. 13:885–890.
Article
2. Hales AM, Chamberlain CG, McAvoy JW. Cataract induction in lenses cultured with transforming growth factor-beta. Invest Ophthalmol Vis Sci. 1995. 36:1709–1713.
3. Lee EH, Joo CK. Role of transforming growth factor-beta in transdifferentiation and fibrosis of lens epithelial cells. Invest Ophthalmol Vis Sci. 1999. 40:2025–2032.
4. Lovicu FJ, Schulz MW, Hales AM, Vincent LN, Overbeek PA, Chamberlain CG, et al. TGF-beta induces morphological and molecular changes similar to human anterior subcapsular cataract. Br J Ophthalmol. 2002. 86:220–226.
Article
5. Cobo LM, Ohsawa E, Chandler D, Arguello R, George G. Pathogenesis of capsular opacification after extracapsular cataract extraction: An animal model. Ophthalmology. 1984. 91:857–863.
Article
6. Lang RA. Which factors stimulate lens fiber cell differentiation in vivo? Invest Ophthalmol Vis Sci. 1999. 40:3075–3078.
7. Klok E, Lubsen NH, Chamberlain CG, McAvoy JW. Induction and maintenance of differentiation of rat lens epithelium by FGF-2, insulin and IGF-1. Exp Eye Res. 1998. 67:425–431.
Article
8. Andley UP, Rhim JS, Chylack LT Jr, Fleming TP. Propagation and immortalization of human lens epithelial cells in culture. Invest Ophthalmol Vis Sci. 1994. 35:3094–3102.
9. Shin SY, Lee HJ, Ko DS, Lee HC, Park WI. The regulators of VEGF expression in mouse ovaries. Yonsei Med J. 2005. 46:679–686.
Article
10. Chung SH, Lee SK, Cristol SM, Lee ES, Lee DW, Seo KY, et al. Impact of short-term exposure of commercial eyedrops preserved with benzalkonium chloride on precorneal mucin. Mol Vis. 2006. 12:415–421.
11. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 2001. 25:402–408.
Article
12. Novotny GEK, Pau H. Myofibroblast-like cells in human anterior capsular cataract. Virchows Arch. 1984. 404:393–401.
Article
13. Hatae T, Ishibashi T, Yoshitomi F, Shibata Y. Immunocytochemistry of types I-IV collagen in human anterior subcapsular cataracts. Graefes Arch Clin Exp Ophthalmol. 1993. 231:586–590.
Article
14. Font RL, Brownstein S. A light and electron microscopic study of anterior subcapsular cataracts. Am J Ophthalmol. 1974. 78:972–984.
Article
15. de Iongh RU, Wederell E, Lovicu FJ, McAvoy JW. Transforming growth factor-beta-induced epithelial-mesenchymal transition in the lens: a model for cataract formation. Cells Tissues Organs. 2005. 179:43–55.
Article
16. Srinivasan Y, Lovicu FJ, Overbeek PA. Lens-specific expression of transforming growth factor beta1 in transgenic mice causes anterior subcapsular cataracts. J Clin Invest. 1998. 101:625–634.
Article
17. Zuk A, Hay ED. Expression of beta1 integrins changes during transformation of avian lens epithelium to mesenchyme in collagen gels. Dev Dyn. 1994. 201:378–393.
Article
18. Daian T, Ohtsuru A, Rogounovitch T, Ishihara H, Hirano A, Akiyama-Uchida Y, et al. Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts. J Invest Dermatol. 2003. 120:956–962.
Article
Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr